Literature DB >> 19708069

Ex vivo and in vivo evaluation of laser-induced thermotherapy for nodular thyroid disease.

Jörg-P Ritz1, Kai S Lehmann, Urte Zurbuchen, Verena Knappe, Thomas Schumann, Heinz J Buhr, Christoph Holmer.   

Abstract

BACKGROUND AND
OBJECTIVE: The prevalence of thyroid nodules ranges between 2% and 60% depending on the population studied. However, minimally invasive procedures like laser-induced thermotherapy (LITT) are increasingly used to treat tumors of parenchymatous organs and seem to be suitable for singular thyroid nodules as well. Their successful clinical application depends on the induction of sufficiently large lesions and a knowledge of the energy parameters required for complete thermal ablation. The aim of this study was to establish a dose-response relationship for LITT of thyroid nodules.
MATERIALS AND METHODS: Thermal lesions were induced in healthy porcine thyroid glands ex vivo (n = 110) and in vivo (n = 10) using an Nd:YAG laser (1,064 nm). Laser energy was applied for 300 seconds in a power range of 10-20 W. During the ablation, continuous temperature measurement at a distance of 5 and 10 mm from the applicator was performed. The lesions were longitudinally and transversally measured, and the volume was calculated. Furthermore, enzyme histochemical analysis of the thyroid tissue was performed.
RESULTS: The maximum inducible lesion volumes were between 0.74 +/- 0.18 cm(3) at a laser power of 10 W and 3.80 +/- 0.41 cm(3) at 20 W. The maximum temperatures after ablation were between 72.9 +/- 2.9 degrees C (10 W) and 112.9 +/- 9.2 degrees C (20 W) at a distance of 5 mm and between 49.5 +/- 2.2 degrees C (10 W) and 73.2 +/- 6.7 degrees C (20 W) at a distance of 10 mm from the applicator. The histochemical analysis demonstrates a complete loss of NADPH dehydrogenase activity in thermal lesions as a sign of irreversible cell damage.
CONCLUSIONS: This study is the first to demonstrate a dose-response relationship for LITT of thyroid tissue. LITT is suitable for singular thyroid nodules and induces reproducible clinically relevant lesions with irreversible cell damage in an appropriate application time.

Entities:  

Mesh:

Year:  2009        PMID: 19708069     DOI: 10.1002/lsm.20805

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  6 in total

1.  Effectiveness of various thermal ablation techniques for the treatment of nodular thyroid disease--comparison of laser-induced thermotherapy and bipolar radiofrequency ablation.

Authors:  Jörg-Peter Ritz; Kai S Lehmann; Thomas Schumann; Verena Knappe; Urte Zurbuchen; Heinz J Buhr; Christoph Holmer
Journal:  Lasers Med Sci       Date:  2011-04-01       Impact factor: 3.161

2.  Endoluminal Nd:YAG laser application in ex vivo biliary porcine tissue.

Authors:  Roberta Rea; Francesco Maria Di Matteo; Margareth Martino; Monica Pandolfi; Paola Saccomandi; Carla Rabitti; Anna Crescenzi; Guido Costamagna
Journal:  Lasers Med Sci       Date:  2017-06-30       Impact factor: 3.161

3.  Machine Learning Prediction of Radiofrequency Thermal Ablation Efficacy: A New Option to Optimize Thyroid Nodule Selection.

Authors:  Roberto Negro; Matteo Rucco; Annalisa Creanza; Alberto Mormile; Paolo Piero Limone; Roberto Garberoglio; Stefano Spiezia; Salvatore Monti; Christian Cugini; Ghassan El Dalati; Maurilio Deandrea
Journal:  Eur Thyroid J       Date:  2019-12-19

Review 4.  Thermal ablation for benign thyroid nodules: radiofrequency and laser.

Authors:  Jung Hwan Baek; Jeong Hyun Lee; Roberto Valcavi; Claudio M Pacella; Hyunchul Rhim; Dong Gyu Na
Journal:  Korean J Radiol       Date:  2011-08-24       Impact factor: 3.500

5.  Unfavorable Outcomes in Solid and Spongiform Thyroid Nodules Treated with Laser Ablation. A 5-Year Follow-up Retrospective Study.

Authors:  Roberto Negro; Gabriele Greco
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2019       Impact factor: 2.895

6.  Percutaneous laser ablation for benign thyroid nodules: a meta-analysis.

Authors:  Wei Fan Sui; Jian Yun Li; Jian Hua Fu
Journal:  Oncotarget       Date:  2017-05-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.